FMC CORP (FMC)       117.02  +0.25 (+0.21%)

117.02  +0.25 (+0.21%)

US3024913036 - Common Stock - After market: 117.02 0 (0%)


Fundamental Rating

Taking everything into account, FMC scores 5 out of 10 in our fundamental rating. FMC was compared to 119 industry peers in the Chemicals industry. FMC has a great profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, FMC is valued expensive at the moment.




Profitability

Profitability Rating


FMC has a Return On Assets of 6.98%. This is better than the industry average of 4.55%.
FMC has a Return On Equity of 24.89%. This is better than the industry average of 13.74%.

FMC has a Profit Margin of 14.64%. This is amongst the best returns in the industry. The industry average is 7.01%. FMC outperforms 88% of its industry peers.
FMC has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for FMC.
VS Industry

ROA (6.98%) VS Industry: 69% outperformed.

-270.86
35.03

ROE (24.89%) VS Industry: 76% outperformed.

0.17
251.50

Profit Margin (14.64%) VS Industry: 88% outperformed.

-88,213.74
91.93

Valuation

Valuation Rating


With a Price/Earnings Ratio of 16.07, FMC is valued correctly.
Compared to an average industry Price/Earning Ratio of 14.74, FMC is valued in line with its industry peers.
With a Forward Price/Earnings Ratio of 13.11, FMC is valued correctly.
FMC's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

With a price book ratio of 4.82, FMC is valued correctly.
Compared to an average industry price book ratio of 2.33, FMC is valued more expensive than its industry peers. 87% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 9.29, FMC is valued more expensive than its industry peers.
VS Industry

Price/Earnings (16.07) VS Industry: 42% outperformed.

240.25
1.64

Price/Book (4.82) VS Industry: 13% outperformed.

31.59
0.01

Enterprise Value/ EBITDA (13.17) VS Industry: 24% outperformed.

97.45
0.63

Growth

Growth Rating


FMC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.60%, which is quite impressive.
Measured over the past 5 years, FMC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.70% on average per year.
Based on estimates for the next 5 years, FMC will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.08% on average per year.
FMC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.36%.

Measured over the past 5 years, FMC shows a quite strong growth in Revenue. The Revenue has been growing by 14.72% on average per year.
The Revenue is expected to grow by 5.52% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS19.7% 3.28% 23.6% 13.49% 13.51% 12.5% 12.08%
Revenue14.72% 5.59% 13.36% 8.15% 6.83% 6.13% 5.52%

Health

Health Rating


FMC has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for FMC.
FMC has a Current Ratio of 1.38. This is a normal value and indicates that FMC is financially healthy and should not expect problems in meeting its short term obligations.
FMC has an Altman-Z score of 2.75. This is not the best score and indicates that FMC is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.82.

When comparing the Current Ratio of FMC to the average industry Current Ratio of 2.21, FMC is less able to pay its short term obligations than its industry peers. 82% of its industry peers have a better Current Ratio.
FMC has a Quick Ratio of 1.38. This is a bad value and indicates that FMC is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 1.52, FMC is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.54, FMC is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.89) VS Industry: 33% outperformed.

9.95
0.00

Quick Ratio (0.97) VS Industry: 25% outperformed.

0.07
107.76

Current Ratio (1.38) VS Industry: 18% outperformed.

0.07
107.76

Altman-Z (2.75) VS Industry: 49% outperformed.

-292.04
236.12

Dividend

Dividend Rating


On average, the dividend of FMC grows each year by 42.75%, which is quite nice.
33.06% of the earnings are spent on dividend by FMC. This is a low number and sustainable payout ratio.
FMC has been paying a dividend for at least 10 years, so it has a reliable track record.
FMC has a Yearly Dividend Yield of 1.79%.

FMC's Dividend Yield is comparable with the industry average which is at 1.87.
Compared to an average S&P500 Dividend Yield of 2.14, FMC has a dividend comparable with the average S&P500 company.
The dividend of FMC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (1.79%) VS Industry: 43% outperformed.

0.31
15.41
FMC Daily chart

FMC CORP117.02

NYSE:FMC (5/16/2022, 7:04:00 PM)+0.25 (+0.21%)

After market: 117.02 0 (0%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 05-02 2022-05-02/amc Earnings (Next) 08-01 2022-08-01
Ins Owners 0.49% Inst Owners 87.58%
Market Cap 14.74B Analysts 74.17
Valuation
PE 16.07 Fwd PE 13.11
PEG (NY) 1.19 PEG (5Y) 0.82
P/S 2.83 P/B 4.82
EV/EBITDA 13.17
Profitability
ROA 6.98% ROE 24.89%
PM 14.64 Asset Turnover 0.48
Growth
EPS 1Y 23.6% EPS 3Y 3.28%
EPS 5Y 19.7% EPS growth Q2Q 22.88%
EPS Next Y 13.49% EPS Next 2Y 13.51%
EPS Next 3Y 12.5% EPS Next 5Y 12.08%
Revenue growth 1Y 13.36% Revenue growth 3Y 5.59%
Revenue growth 5Y 14.72% Revenue growth Q2Q 12.98%
Revenue Next Year 8.15% Revenue Next 2Y 6.83%
Revenue Next 3Y 6.13% Revenue Next 5Y 5.52%
Health
Current Ratio 1.38 Quick Ratio 0.97
Altman-Z 2.75 F-Score 7
Debt/Equity 0.89
Dividend
Dividend Yield 1.79% Dividend Growth 42.75%
DP 33.06% Ex-Date 03-30 2022-03-30 (0.53)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA